In 2002 the Department of Immunology, Microbiology and Parasitology at the UPV/EHU together with the company, Laboratorios Bromatol?gicos Araba, and the Leioa Technological Centre, decided to carry out collaborative work in order to try to develop new, faster methods for Salmonella detection.
CNRS laboratory IN2P3 in an international effort analyzed close to 80,000 medicines for Malaria allowing the calculation of the probability of a particular molecule affecting the proliferation of the parasite.
CNRS France and a team of Portuguese researchers at the Istitut Pasteur have just identified a protein in a micro-organism which allows it to colonise a host by modulating its immune system and may show the way to combat Group B Streptococci.
CNRS researchers at the University Victor S?galen, Bordeaux have revealed the existence of an interaction at the cellular level between cognitive information and motor information.
There is accumulating data that suggests in addition to directly killing tumor cells, reoviruses may prime the immune system to mount a separate, powerful and long lasting defense against cancer.
More than 7,000 deaths and 27,000 cardiovascular events, such as heart attacks, can be avoided over the next five years by modernising the prevention and treatment of coronary heart disease (CHD), the Scottish Intercollegiate Guidelines Network (SIGN) said.
Medical authorities hope the cholera outbreak in the Republic of Congo has been contained as no more deaths have been reported since Sunday.
The U.S. Food and Drug Administration (FDA) today cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman’s initial cancer.
When cells go about the business of dividing, they can get sidelined. Maybe there aren’t enough nutrients. Maybe there aren’t the right signals to resume multiplying. Either way, cells go quiet.
A toxin derived from a reclusive sea creature resembling a translucent doughnut has inspired UT Southwestern Medical Center researchers to develop a related compound that shows promise as a cancer treatment.